Synthetic fibrinolytic agents.
D045930:Anabolic Agents / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D004789:Enzyme Activation; D004837:Epinephrine / Q000494:pharmacology; D005337:Fibrin / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology; D010958:Plasminogen / Q000378:metabolism; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors; D015849:Plasminogen Inactivators; D013927:Thrombosis / Q000517:prevention & control; D014667:Vasopressins / Q000494:pharmacology
D045930:Anabolic Agents; D002395:Catecholamines; D005343:Fibrinolytic Agents; D007004:Hypoglycemic Agents; D009539:Nicotinic Acids; D015849:Plasminogen Inactivators; D014667:Vasopressins; D005337:Fibrin; D010958:Plasminogen; D010960:Plasminogen Activators; D005341:Fibrinolysin; D004837:Epinephrine